Genmab A/S (GMAB.CO)
Copenhagen - Copenhagen Real-time price. Currency in DKK
Add to watchlist
At close: 04:59PM CEST
| Previous close | 1,799.00 |
| Open | 1,782.50 |
| Bid | 1,791.50 x N/A |
| Ask | 1,793.00 x N/A |
| Day's range | 1,777.50 - 1,817.50 |
| 52-week range | 1,751.50 - 2,814.00 |
| Volume | |
| Avg. volume | 145,566 |
| Market cap | 114.468B |
| Beta (5Y monthly) | 0.81 |
| PE ratio (TTM) | 21.60 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Insider Monkey
Genmab A/S (NASDAQ:GMAB) Q1 2024 Earnings Call Transcript
Genmab A/S (NASDAQ:GMAB) Q1 2024 Earnings Call Transcript May 2, 2024 Genmab A/S reports earnings inline with expectations. Reported EPS is $0.16 EPS, expectations were $0.16. Genmab A/S isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Hello, and welcome to […]
- GuruFocus.com
Comstock Inc (LODE) Q1 2024 Earnings Call Transcript Highlights: Strategic Investments and ...
Explore key insights from Comstock Inc's Q1 2024 earnings, including significant revenue streams, strategic investments, and future financial strategies.
- Investor's Business Daily
Genmab Takes The Next Step In Its 'Evolution' With A $1.8 Billion Takeover
Genmab stock slumped Wednesday after the Danish biotech announced it will buy privately held ProfoundBio for $1.8 billion.
© 2024 Yahoo. All rights reserved.